Archived Webinar

Opportunities for Real World Data in Diagnostics

Recorded on March 10, 2021

Suzanne Belinson PhD, MPH, Vice President of Commercial Markets
Tempus Labs Inc.

Topics Include:

  • Defining RWD specific to diagnostic tests to satisfy payers
  • Generation of RWD: focus on clear clinical study end-points
  • Weight of real-world evidence in the coverage review process

PRICING
This webinar is available to single attendees for $249.

TARGETED AUDIENCES
Reimbursement
Market Access
Payer Relations/Payer Policy

INDUSTRIES REPRESENTED
Diagnostics

Presenter:

Suzanne Belinson PhD, MPH, Vice President of Commercial Markets
Tempus Labs Inc.

Suzanne Belinson, PhD, MPH, is Vice President of Commercial Markets at Tempus Labs Inc. Tempus is a technology company that is making precision medicine a reality by gathering and analyzing clinical and molecular data at scale. Her role focuses on commercial growth for Tempus through the development and execution of partnerships with managed care organizations aiming to improve healthcare value by leveraging data.

Before joining Tempus, Dr. Belinson served as Executive Director, Clinical Markets, at the Blue Cross Blue Shield Association.

For More Information, Contact:

Brooke AkinsBrooke Akins
Division Director, Life Science Programs
+1 (312) 224-1693 
bakins@q1productions.com​